Actively Recruiting
Long-term Study on AI-Assisted Colonoscopy to Lower Risk of Advanced Colonic Lesions
Led by The University of Hong Kong · Updated on 2026-03-12
404
Participants Needed
1
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether using artificial intelligence AI-assisted colonoscopy can reduce the risk of developing advanced colonic lesions during follow-up colonoscopies. The study focuses on patients who previously underwent either AI-assisted or conventional colonoscopy to see if AI technology decreases the likelihood of metachronous advanced lesions over time. Participants will have surveillance colonoscopies to monitor for the presence of advanced colonic lesions after their initial colonoscopy. This procedure is the main intervention being studied, and the trial compares outcomes between those who previously had AI-assisted colonoscopy and those who had standard colonoscopy. Throughout the study, participants will undergo surveillance colonoscopy at intervals to assess the development of colonic lesions. Researchers will measure the cumulative risk of metachronous advanced lesions over three years, along with secondary outcomes such as the number and types of adenomas and serrated lesions detected. The trial includes safety monitoring and informed consent, with participation lasting at least three years from the initial procedure.
CONDITIONS
Brief Title
The Long-term Effect of Artificial Intelligence-assisted Colonoscopy on Risk of Metachronous Advanced Colonic Lesion
Research Team
T
Thomas KL Clinical Assoicate Professor, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here